Delivery Order SPE2DR25D3303-SPE2DR26F63D9
Award Date 12/9/25
Potential Completion Date 12/10/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,184.11 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. This non-competitive delivery order, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed price transaction under DLA's pharmaceutical supply chain. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $55,087.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. The award, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a non-set-aside competitive procurement supporting federal medical supply needs. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,240.92 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. This competitive award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price transaction with no set-aside designation. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the company's role as a critical...
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- The Defense Logistics Agency awarded a $10,558.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The award was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order representing a routine pharmaceutical supply transaction through the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $51,402.86 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods, with a completion date of September 29, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, and the products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $9,190.25 to AmerisourceBergen Drug Corp on September 4, 2025, for OmniPod 5 Dexcom G7 insulin delivery pods (Generation 5), with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to the federal government. The delivery will be fulfilled from the vendor's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $3,071.69 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. The non-competitive delivery order was issued on November 26, 2025, with an ultimate completion date of November 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a firm fixed-price transaction utilizing existing contract authority under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $22,724.78 to AmerisourceBergen Drug Corp for the supply of OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 8, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive role in federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.73 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...